Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BUB1 | O43683 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | MT-CO2 | P00403 | 1/20 | 0.37 |
| ▸ | TTR | P02766 | 1/20 | 0.37 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | PGR | P06401 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | HTR1A | P08908 | 1/20 | 0.37 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.37 |
| ▸ | AR | P10275 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18871411 | 0.78 | ALDH1A1 (0.34) | MAPTALDH1A1KMT2ASMN1; SMN2LMNA | |
| SCHEMBL13640179 | 0.75 | ALDH1A1 (0.42) | MAPTALDH1A1KMT2ASMN1; SMN2LMNA | |
| SCHEMBL18871544 | 0.74 | ALDH1A1 (0.41) | MAPTALDH1A1KMT2ASMN1; SMN2LMNA | |
| SCHEMBL13640458 | 0.73 | MEN1 (0.46) | BUB1MAPTALDH1A1KMT2ALMNA | |
| SCHEMBL11887914 | 0.73 | KDR (0.50) | MAPTALDH1A1KMT2ASMN1; SMN2LMNA | |
| SCHEMBL13640140 | 0.72 | PKM (0.46) | BUB1MAPTALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL22056805 | 0.72 | ALDH1A1 (0.43) | BUB1MAPTALDH1A1KMT2ARECQL | |
| SCHEMBL22057718 | 0.72 | MAOA (0.45) | BUB1MAPTALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL13640143 | 0.71 | ALDH1A1 (0.46) | BUB1MAPTALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL13640438 | 0.71 | ALDH1A1 (0.44) | MAPTALDH1A1KMT2ASMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2477491-B1 | PLANT ADDITIVES AND USES THEREOF TO MODULATE THE SYNTHESIS OF MEMBRANE GLYCEROLIPIDS IN PLANTS | COMMISSARIAT L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2017-05-17 | — | — | EP | disclosed |
| US-9028855-B2 | Plant additives and uses thereof to modulate the synthesis of membrane glycerolipids in planta | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2015-05-12 | — | — | US | disclosed |
| US-9028855-B2 | Plant additives and uses thereof to modulate the synthesis of membrane glycerolipids in planta | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2015-05-12 | — | — | US | disclosed |
| US-20120283101-A1 | Plant Additives and Uses Thereof to Modulate the Synthesis of Membrane Glycerolipids in Planta | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2012-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120283101-A1 | Plant Additives and Uses Thereof to Modulate the Synthesis of Membrane Glycerolipids in Planta | PGM2, SGMS2, PHOSPHO1 | BUB1 3024/4885MAPT 4242/4885ALDH1A1 3248/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.